HCPCS Level II code C1605 represents implantation of a leadless, dual-chamber (right atrial and right ventricular) rate-responsive pacemaker, including all components required for implantation. This code captures a newer device category that aims to provide dual-chamber pacing without transvenous leads, with implications for procedural workflow, device supply, and reimbursement pathways across payers. Nationally, adoption affects hospital implant programs, electrophysiology service lines, and device procurement strategies.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage and reimbursement benchmarks, coding and billing considerations tied to device implantation services, and the clinical context for patient selection and site-of-service planning. The publication summarizes how C1605 is used to represent the complete implanted system, typical places of service where implantation occurs, and common billing modifiers associated with complex procedures. It also outlines areas where payers may apply medical necessity criteria or prior authorization for advanced implantable cardiac devices.

This resource is intended for hospital billing managers, electrophysiology clinicians, revenue cycle leaders, and payer policy analysts seeking a national-level briefing on code C1605, associated clinical service, and the billing context for leadless dual-chamber pacemaker implantation.